Authors: Terri A. deRoon-Cassini; Carisa L. Bergner; Samantha A. Chesney; Nicholas R. Schumann; Tara Sander Lee; Karen J. Brasel; Cecilia J. Hillard · Research
Can Blood Markers Help Predict Who Will Develop PTSD After Trauma?
Research examining blood biomarkers and genetic factors that could help predict PTSD risk after traumatic injury
Source: deRoon-Cassini, T. A., Bergner, C. L., Chesney, S. A., Schumann, N. R., Lee, T. S., Brasel, K. J., & Hillard, C. J. (2022). Circulating endocannabinoids and genetic polymorphisms as predictors of posttraumatic stress disorder symptom severity: heterogeneity in a community-based cohort. Translational Psychiatry, 12(1), 48.
What you need to know
- About 30% of people develop PTSD after traumatic injury, but it’s hard to predict who will be affected
- Researchers found certain blood markers and genetic factors measured right after trauma may help identify those at higher risk
- Women and racial minorities showed different patterns in these biomarkers compared to white men
Understanding Trauma’s Impact on Mental Health
Imagine arriving at an emergency room after a serious car accident or injury. While doctors focus on treating your physical wounds, there’s another invisible battle that may lie ahead - the psychological aftermath of trauma. For some people, this leads to post-traumatic stress disorder (PTSD), a condition that can cause flashbacks, nightmares, anxiety and other debilitating symptoms. But why do some people develop PTSD while others recover without lasting psychological effects?
The Role of Endocannabinoids
Our bodies have a natural stress-response system called the endocannabinoid system. This system helps regulate fear, anxiety, and emotional memory - all key factors in PTSD. The system involves two main molecules: AEA and 2-AG. These act like the body’s own cannabis-like substances, helping to modulate our response to stress and trauma.
What the Research Found
Researchers studied 170 trauma patients, measuring their endocannabinoid levels both during initial hospitalization and 6-8 months later. They also looked at specific genes involved in endocannabinoid function.
Surprisingly, they found that people who developed PTSD had higher levels of these endocannabinoids right after trauma - the opposite of what many expected based on previous research. This suggests the relationship between these molecules and PTSD risk is more complex than previously thought.
Important Differences Between Groups
One of the most striking findings was how these patterns differed between demographic groups:
- Women showed stronger correlations between endocannabinoid levels and PTSD symptoms
- Racial minorities had distinct patterns compared to white participants
- Genetic variations affected PTSD risk differently in different groups
What This Means for You
While this research is still in early stages, it highlights several important points:
- The psychological impact of trauma varies significantly between individuals
- Biological factors may help predict PTSD risk
- Prevention and treatment strategies may need to be tailored for different groups
Conclusions
- Early biological markers might help identify people at higher risk for PTSD after trauma
- The stress response system works differently in different demographic groups
- More research is needed to develop targeted prevention strategies based on these findings